Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia

Autoimmunity Reviews

Volumn 4, Issue 5, 2005, Pages 264-269

  Mouthon, Luc ^a   Guillevin, Loïc ^a   Tellier, Zera ^b  

^a Assistance Publique Hôpitaux de Paris and Université Paris V ^*  (France)

^b Laboratoire Francais du Fractionnement et des Biotechnologies   (France)

Author keywords

Autoimmunity; Intravenous immunoglobulins; Parvovirus B19; Pure red cell aplasia

Indexed keywords

CD4 ANTIGEN; ERYTHROPOIETIN; IMMUNOGLOBULIN;

BONE MARROW; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG INDUCED DISEASE; ERYTHEMA INFECTIOSUM; ERYTHROID PRECURSOR CELL; HOST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNE DEFICIENCY; IMMUNE DEFICIENCY; INFUSION; LYMPHOPROLIFERATIVE DISEASE; MAINTENANCE THERAPY; ORGAN TRANSPLANTATION; PARVOVIRUS; PREGNANCY; PURE RED CELL ANEMIA; REVIEW; THYMOMA; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME;

AUTOIMMUNE DISEASES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; RED-CELL APLASIA, PURE;

EID: 21244459462     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2004.10.004     Document Type: Review

References (40)

1. L.F. Diehl, and L.H. Ketchum Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia Semin. Oncol. 25 1998 80 97
2. N.S. Young Parvovirus infection and its treatment Clin. Exp. Immunol. 104 1996 26 30
3. A. Raghavachar Pure red cell aplasia: review of treatment and proposal for a treatment strategy Blut 61 1990 47 51
4. M. Bjorkholm Intravenous immunoglobulin treatment in cytopenic haematological disorders J. Intern. Med. 234 1993 119 126
5. J.P. Clauvel, W. Vainchenker, and A. Herrera Treatment of pure red cell aplasia by high dose intravenous immunoglobulins Br. J. Haematol. 55 1983 380 382
6. A. Etzioni, D. Atias, and S. Pollack Complete recovery of pure red cell aplasia by intramuscular gammaglobulin therapy in a child with hypoparathyroidism Am. J. Hematol. 22 1986 409 414
7. W.A. McGuire, H.H. Yang, and E. Bruno Treatment of antibody-mediated pure red-cell aplasia with high-dose intravenous gamma globulin N. Engl. J. Med. 317 1987 1004 1008
8. S.W. Needleman Durable remission of pure red cell aplasia after treatment with high-dose intravenous gammaglobulin and prednisone Am. J. Hematol. 32 1989 150 152
9. O.F. Ballester, H.I. Saba, L.C. Moscinski, R. Nelson, and P. Foulis Pure red cell aplasia: treatment with intravenous immunoglobulin concentrate Semin. Hematol. 29 1992 106 108
10. C. Larroche, L. Mouthon, N. Casadevall, G. Le Roux, P. Casassus, and L. Guillevin Successful treatment of thymoma-associated pure red cell aplasia with intravenous immunoglobulins Eur. J. Haematol. 65 2000 74 76
11. Y. Ilan, and Y. Naparstek Pure red cell aplasia associated with systemic lupus erythematosus: remission after a single course of intravenous immunoglobulin Acta Haematol. 89 1993 152 154
12. G.D. Linardaki, K.A. Boki, A. Fertakis, and A.G. Tzioufas Pure red cell aplasia as presentation of systemic lupus erythematosus: antibodies to erythropoietin Scand. J. Rheumatol. 28 1999 189 191
13. S. Sumimoto, M. Kawai, Y. Kasajima, and T. Hamamoto Intravenous gamma-globulin therapy in diamond-blackfan anemia Acta Paediatr. Jpn. 34 1992 179 180
14. J.L. Huang, I.J. Hung, L.C. Chen, W.Y. Lee, C. Hsueh, and K.H. Hsieh Successfully treated sulphasalazine-induced fulminant hepatic failure, thrombocytopenia and erythroid hypoplasia with intravenous immunoglobulin Clin. Rheumatol. 17 1998 349 352
15. G. Kurtzman, N. Frickhofen, J. Kimball, D.W. Jenkins, A.W. Nienhuis, and N.S. Young Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy N. Engl. J. Med. 321 1989 519 523
16. S.H. Choi, S.P. Chang, J.C. Won, J.S. Lee, H.S. Chi, and W.S. Yang A case of persistent anemia in a renal transplant recipient: association with parvovirus B19 infection Scand. J. Infect. Dis. 34 2002 71 75
17. A. Moudgil, H. Shidban, and C.C. Nast Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin Transplantation 64 1997 1847 1850
18. G. Neild, M. Anderson, S. Hawes, and B.T. Colvin Parvovirus infection after renal transplant Lancet 2 1986 1226 1227
19. N. al-Khaldi, A.R. Watson, A. Harris, and W.L. Irving Dual infection with human herpes virus type 6 and parvovirus B19 in a renal transplant recipient Pediatr. Nephrol. 8 1994 349 350
20. Y.K. Keung, T. Chuahirun, and D. Wesson Concomitant parvovirus B19 and cytomegalovirus infections after living-related renal transplantation Nephrol. Dial. Transplant. 14 1999 469 471
21. L. Murer, G. Zacchello, and D. Bianchi Thrombotic microangiopathy associated with parvovirus B19 infection after renal transplantation J. Am. Soc. Nephrol. 11 2000 1132 1137
22. D. Geetha, J.B. Zachary, H.M. Baldado, J.D. Kronz, and E.S. Kraus Pure red cell aplasia caused by parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature Clin. Transplant. 14 2000 586 591
23. G.A. Bergen, P.E. Sakalosky, and J.T. Sinnott Transient aplastic anemia caused by parvovirus B19 infection in a heart transplant recipient J. Heart Lung Transplant. 15 1996 843 845
24. J. Wicki, K. Samii, P. Cassinotti, J. Voegeli, T. Rochat, and P. Beris Parvovirus B19-induced red cell aplasia in solid-organ transplant recipients. Two case reports and review of the literature Hematol. Cell Ther. 39 1997 199 204
25. S. Suzuki, Y. Osaka, and I. Nakai Pure red cell aplasia induced by FK506 Transplantation 61 1996 831 832
26. S. Misra, T.B. Moore, M.E. Ament, R.W. Busuttil, and S.V. McDiarmid Red cell aplasia in children on tacrolimus after liver transplantation Transplantation 65 1998 575 577
27. P.R. Koduri Parvovirus B19-related anemia in HIV-infected patients AIDS Patient Care STDs 14 2000 7 11
28. P.R. Koduri, R. Kumapley, J. Valladares, and C. Teter Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: use of intravenous immunoglobulin-a report of eight patients Am. J. Hematol. 61 1999 16 20
29. F. Gottlieb, and J. Deutsch Red cell aplasia responsive to immunoglobulin therapy as initial manifestation of human immunodeficiency virus infection Am. J. Med. 92 1992 331 333
30. E. Mylonakis, B.P. Dickinson, and M.D. Mileno Persistent parvovirus B19 related anemia of seven years' duration in an HIV-infected patient: complete remission associated with highly active antiretroviral therapy Am. J. Hematol. 60 1999 164 166
31. J.J. Goedert, D.D. Erdman, and B.A. Konkle Parvovirus B19 quiescence during the course of human immunodeficiency virus infection in persons with hemophilia Am. J. Hematol. 56 1997 248 251
32. J.R. Arribas, J.M. Pena, and J.E. Echevarria Parvovirus B19-related anemia in an HIV-infected patient: rapid control after production of neutralizing antibodies during highly active antiretroviral therapy Ann. Intern. Med. 132 2000 1011
33. K. Seyama, R. Kobayashi, and H. Hasle Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome J. Infect. Dis. 178 1998 318 324
34. T. Chuhjo, S. Nakao, and T. Matsuda Successful treatment of persistent erythroid aplasia caused by parvovirus B19 infection in a patient with common variable immunodeficiency with low-dose immunoglobulin Am. J. Hematol. 60 1999 222 224
35. G. Nigro, P. D'Eufemia, M. Zerbini, A. Krzysztofiak, R. Finocchiaro, and O. Giardini Parvovirus B19 infection in a hypogammaglobulinemic infant with neurologic disorders and anemia: successful immunoglobulin therapy Pediatr. Infect. Dis. J. 13 1994 1019 1021
36. A. Selbing, A. Josefsson, L.O. Dahle, and R. Lindgren Parvovirus B19 infection during pregnancy treated with high-dose intravenous gammaglobulin Lancet 345 1995 660 661
37. V.R. Sharma, D.R. Fleming, and S.P. Slone Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab Blood 96 2000 1184 1186
38. K.W. Song, P. Mollee, B. Patterson, W. Brien, and M. Crump Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphoma Br. J. Haematol. 119 2002 125 127
39. D. Verhelst, J. Rossert, N. Casadevall, L. MacDougall, A. Kruger, and K. Eckart Treatment of antibody-mediated pure red cell aplasia J. Am. Soc. Nephrol. 14 2003 27A
40. F. Hayakawa, K. Imada, M. Towatari, and H. Saito Life-threatening human parvovirus B19 infection transmitted by intravenous immune globulin Br. J. Haematol. 118 2002 1187 1189